Evidence map›Paper›PMID 39697613›Full record

ArticleDEN open2025

Prevalence of gastric cancer following colorectal endoscopic submucosal dissection for lesions more than 20 mm: A retrospective analysis.

Yuri Tomita, Naohisa Yoshida, Hideki Ishikawa, Takahiro Otani, Reo Kobayashi, Hikaru Hashimoto, Ryohei Hirose, Osamu Dohi, Ken Inoue, Yukiko Morinaga and 1 more

Abstract read
In one paragraph

Article in DEN open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuri TomitaDepartment of Gastroenterology Koseikai Takeda Hospital Kyoto Japan.ORCID https://orcid.org/0000-0003-3244-6894
Naohisa YoshidaDepartment of Molecular Gastroenterology and Hepatology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan.ORCID https://orcid.org/0000-0001-6167-9705
Hideki IshikawaDepartment of Molecular-Targeting Prevention Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan.
Takahiro OtaniDepartment of Public Health Nagoya City University Graduate School of Medical Sciences Aichi Japan.
Reo KobayashiDepartment of Molecular Gastroenterology and Hepatology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan.
Hikaru HashimotoDepartment of Gastroenterology Osaka General Hospital of West Japan Railway Company Osaka Japan.ORCID https://orcid.org/0000-0002-7429-705X
Ryohei HiroseDepartment of Molecular Gastroenterology and Hepatology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan.
Osamu DohiDepartment of Molecular Gastroenterology and Hepatology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan.ORCID https://orcid.org/0000-0002-0498-0144
Ken InoueDepartment of Molecular Gastroenterology and Hepatology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan.
Yukiko MorinagaDepartment of Surgical Pathology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan.
Yoshito ItohDepartment of Molecular Gastroenterology and Hepatology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Colorectal endoscopic submucosal dissection (ESD) for large tumors is spreading worldwide. Gastric cancer (GC) sometimes occurs after colorectal ESD. However, its status including frequency and risk factors have not been examined well. In this study, we analyzed the detailed status of GC after colorectal ESD. Methods: This was a single-center retrospective study. Patients receiving colorectal ESD between 2010 and 2018 were reviewed. All patients were recommended to receive esophagogastroduodenoscopy (EGD) for screening. Finally, 436 patients receiving EGD, who underwent colorectal ESD for lesions of ≥20 mm were analyzed. The primary outcome was the GC rate after colorectal ESD, including intramucosal cancer. As a control, we compared it to the GC rate in matched Japanese national cancer registry data. The secondary outcome was risk factors for developing GC. Results: The mean age was 66.9 ± 10.6 and 55.3% were males. The GC rate was 5.96% (26/436) with a median observation period of 27 months. It was significantly higher than the mean GC rate in the diagnosed age calculated with the cancer registry (0.26%, observed value/expected value ratio [95% confidence interval]: 22.20 [14.50-32.53], Conclusion: The GC rate was high after resecting colorectal tumors of ≥20 mm, suggesting the necessity of EGD.

Indexed as

colonoscopycolorectal neoplasmsendoscopic submucosal dissectionesophagogastroduodenoscopygastric cancer

Identifiers

PMID39697613
PMCPMC11653160

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.